APA (7th ed.) Citation

Lindeman, N. I., Cagle, P. T., Beasley, M. B., Chitale, D. A., Dacic, S., Giaccone, G., . . . Ladanyi, M. (2013). Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors. Archives of Pathology & Laboratory Medicine, 137(6), 828. https://doi.org/10.5858/arpa.2012-0720-OA

Chicago Style (17th ed.) Citation

Lindeman, Neal I., et al. "Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors." Archives of Pathology & Laboratory Medicine 137, no. 6 (2013): 828. https://doi.org/10.5858/arpa.2012-0720-OA.

MLA (9th ed.) Citation

Lindeman, Neal I., et al. "Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors." Archives of Pathology & Laboratory Medicine, vol. 137, no. 6, 2013, p. 828, https://doi.org/10.5858/arpa.2012-0720-OA.